ArticleChinese medicine2026
Eerdun Wurile, a Mongolian medicine, alleviates neuronal damage and improves neurological dysfunction after cerebral hemorrhage by activating the PI3K/AKT signaling pathway.
Article in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThis study aims to evaluate the neuroprotective effects of the Mongolian medicine Eerdun Wurile (EW) against intracerebral hemorrhage (ICH) and explore its underlying mechanisms. ICH, a severe subtype of stroke, is characterized by a complex pathological process, with no specific treatments currently available. EW, a traditional Mongolian medicinal formula, has a long history of use in treating central nervous system disorders, but its mechanism of action in ICH remains poorly understood.
methodsA mouse model of ICH was induced through stereotactic intracerebral injection of Collagenase Type IV. Behavioral assessments, histological examinations, and RNA sequencing were conducted to assess the effects of EW and elucidate its mechanism of action in mitigating neuronal injury post-cerebral hemorrhage.
resultsEW administration improved a range of ICH-induced deficits, including neurological and neurofunctional impairments, anxiety-like behaviors, and cognitive dysfunction. EW protected neurons from injury and apoptosis in both in vitro and in vivo models. Additionally, EW treatment suppressed the activation of astrocytes and microglia, reducing neuroinflammation, preserving blood-brain barrier integrity, and alleviating synaptic damage. RNA-seq analysis revealed that the PI3K/AKT signaling pathway plays a key role in EW's neuroprotective effects. EW activates this pathway, modulating the balance of Bcl-2 family proteins, thereby reducing neuronal apoptosis.
conclusionEW confers neuroprotection through multiple mechanisms. These findings provide strong experimental evidence supporting the potential clinical application of EW as a therapeutic agent for ICH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.